nivolumab
bms
['nivo', 'nivolumab']
no difference with peri operative nivolumab in #kidneycancer prosper. because there was neoadjuvant component 10% were t1 tumors and there was contamination (eg not getting nivo or surgery). so many subgroups and questions to look at. #oncoalert #esmo22 
A medical oncologist that specializes in and focuses his research on urologic cancers.